AKRX News Alert Akorn Inc (AKRX) 37.55 12/17/2014 02:59:00

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Akorn Inc (AKRX) 37.55 $AKRX

Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 5:20PM CST
Actavis plc (ACT) announced its decision to file an emergency appeal for an immediate overturn of the lower court ruling that will require the company to continue selling Namenda IR.
IPXL: 29.09 (-1.55), ACT: 256.52 (-6.48), AKRX: 37.55 (-2.17), MYL: 53.56 (-0.96)

Stocks Mixed In Volatile Session; Boeing Boosts Dow
at Investor's Business Daily - Tue Dec 16, 2:04PM CST
Stocks wavered and were mixed heading into the final hour Tuesday. The Dow clung to a 0.2% gain, while the S&P 500 added a fraction and the Nasdaq fell 0.4%. Volume was tracking mildly higher across the board. The Russell 2000 outperformed in the...
AKRX: 37.55 (-2.17), BA: 124.25 (+2.17), BCPC: 65.24 (+1.89), MMS: 51.00 (+0.67)

Great Stocks: Drugmaker Akorn Works On Base
at Investor's Business Daily - Mon Dec 15, 5:33PM CST
Generic-drug maker Akorn is among a few stocks in the Spotlight screen that is working on a base. Even better, the pattern is second stage, which has a better chance of success than a base that forms later in a stock's advance. The potential buy...
AKRX: 37.55 (-2.17)

Insider Trading Alert - AHC, AKRX And CNBKA Traded By Insiders
at The Street - Mon Dec 15, 9:30AM CST
Stocks with insider trader activity include AHC, AKRX and CNBKA
CNBKA: 39.89 (+0.54), AHC: 12.17 (-0.03), AKRX: 37.55 (-2.17)

Why Akorn (AKRX) is Poised to Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 8:03AM CST
Akorn has seen a nice streak of beating earnings estimates at the previous two reports and might be in a good position to beat earnings at its next report
AKRX: 37.55 (-2.17)

Actavis Likely to Continue Selling Namenda IR Tablets - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 2:20PM CST
Actavis plc (ACT) may face an injunction under which the company will have to continue selling Namenda IR.
IPXL: 29.09 (-1.55), ACT: 256.52 (-6.48), AKRX: 37.55 (-2.17), MYL: 53.56 (-0.96)

Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines
PR Newswire - Fri Dec 12, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Pfizer Inc. (NYSE: PFE), Merck and Company Inc. (NYSE: MRK), AbbVie Inc. (NYSE: ABBV), Akorn Inc. (NASDAQ: AKRX), and The Medicines Company (NASDAQ: MDCO). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, December 11, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,596.34, up 0.36% and the NASDAQ Composite closed at 4,708.16, up 0.52%. The S&P 500 finished the session 0.45% higher at 2,035.33. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 806.11, up 0.26%, with the index advancing 8.67% in the previous three months. Register for your complimentary reports on these five stocks at:
MDCO: 26.38 (+1.24), AKRX: 37.55 (-2.17), MRK: 56.80 (-0.15), PFE: 30.67 (-0.19), ABBV: 65.25 (-0.37)

Supernus Faces another Patent Challenge for Oxtellar XR - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 2:20PM CST
Supernus Pharmaceuticals, Inc. (SUPN) received a Para IV notice from TWi Pharma, seeking approval for its generic version of Supernus' Oxtellar XR in the U.S.
ACT: 256.52 (-6.48), AKRX: 37.55 (-2.17), SUPN: 8.72 (+0.08), MYL: 53.56 (-0.96)

Supernus Faces New Patent Challenge for Trokendi XR - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 1:50PM CST
Supernus Pharmaceuticals, Inc. (SUPN) received a Paragraph IV notice from Par, which is looking to get its generic version of Supernus' Trokendi XR approved in the U.S.
ACT: 256.52 (-6.48), AKRX: 37.55 (-2.17), SUPN: 8.72 (+0.08), MYL: 53.56 (-0.96)

Energy Sector Drags On Stocks; Lakeland, Spirit, Akorn Rise
at Investor's Business Daily - Wed Dec 10, 9:28AM CST
Stocks opened in the hole Wednesday, posting quiet losses as energy stocks suffered many of the largest early declines. The Dow Jones industrial average and the S&P 500 each slipped 0.6%. The Nasdaq shed 0.4%. Volume was sharply lower, as the stock...
SAVE: 68.70 (+0.11), AKRX: 37.55 (-2.17), COST: 137.31 (-0.88), LAKE: 9.19 (-0.46), XOM: 86.41 (-0.49), VRA: 20.11 (+0.33), FRAN: 15.97 (+0.03), KKD: 19.35 (+0.06), CVX: 101.70 (+0.84), TOL: 30.92 (-0.28), HOV: 3.78 (-0.24)

Akorn Rises 3.50% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Dec 09, 5:10PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $39.01 to a high of $41.31. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $40.50 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 37.55 (-2.17)

Stocks Snap Back After Morning Downdraft; AutoZone Jumps
at Investor's Business Daily - Tue Dec 09, 3:16PM CST
Major averages recovered early losses Tuesday, an impressive performance considering the carnage in overseas markets overnight. At the close, the Nasdaq turned a 1.4% intraday loss into a 0.5% gain. The S&P 500 also fell more than 1% in the morning...
T: 32.14 (-0.11), BIDU: 219.96 (-5.85), SAVE: 68.70 (+0.11), AAP: 157.01 (-4.00), AZO: 597.93 (-7.91), AKRX: 37.55 (-2.17), ORLY: 190.17 (-2.04), DATA: 80.32 (-1.26), VZ: 45.53 (+0.11), BABA: 105.77 (+1.07)

Stocks Recover After Sharp Losses; Nasdaq Turns Positive
at Investor's Business Daily - Tue Dec 09, 2:01PM CST
Major averages recovered well above session lows Tuesday, an impressive performance amid a sell-off in China and European markets. The Dow Jones industrial average lost 0.5%, weighed down by Verizon (VZ) and AT&T (T). The S&P 500 eased 0.3% after...
CAVM: 58.14 (-1.02), T: 32.14 (-0.11), SAVE: 68.70 (+0.11), AZO: 597.93 (-7.91), AKRX: 37.55 (-2.17), HQY: 22.74 (-0.16), VZ: 45.53 (+0.11)

Stocks Swoon In Heavy Trade; Spirit Airlines Spirals Lower
at Investor's Business Daily - Tue Dec 09, 9:38AM CST
Stocks opened to broad and breathtaking losses Tuesday, as harsh selling overseas and weakened energy prices took a bite out of investor confidence. The Nasdaq tumbled 1.1% at the starting bell. The S&P 500 and the Dow Jones industrial average fell...
AMBA: 45.78 (-0.35), TSLA: 197.81 (-6.23), MNST: 106.24 (+1.23), GPRO: 58.27 (+1.27), CAVM: 58.14 (-1.02), AKRX: 37.55 (-2.17), KFY: 27.84 (+0.67), SAVE: 68.70 (+0.11), HQY: 22.74 (-0.16), MRK: 56.80 (-0.15), KKD: 19.35 (+0.06), VZ: 45.53 (+0.11)

Actavis' Antibiotic Backed for FDA Approval, Response in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 5:30PM CST
Actavis' (ACT) ceftazidime-avibactam got favorable recommendation from the Anti-Infective Drugs Advisory Committee for the treatment of complicated intra-abdominal infections and complicated urinary tract infections.
ACT: 256.52 (-6.48), CBST: 96.73 (+0.42), AKRX: 37.55 (-2.17), AZN: 69.56 (-0.18)

Stocks Sink In Late Trading: Tesla, McDonald's Dive
at Investor's Business Daily - Mon Dec 08, 2:06PM CST
Stocks stretched losses heading into the final hour of trading Monday. In the stock market today the Nasdaq fell 0.9%, the S&P 500 dropped 0.7%, and the Dow trimmed 0.6%. Volume was tracking higher across the board compared with Friday's levels. From...
TSLA: 197.81 (-6.23), AKRX: 37.55 (-2.17), UTX: 113.23 (+1.32), JAZZ: 159.65 (-2.95), MCD: 88.72 (+0.26), CELG: 110.09 (-1.79)

Stock Market Today: Jazz Hits New High, In Buy Range
at Investor's Business Daily - Mon Dec 08, 11:02AM CST
Stocks were lower at midday Monday following mixed overseas economic data. The Nasdaq was up 0.1%, while the S&P 500 and the Dow Jones industrial average were each off a fraction. Volume was tracking lower on both major exchanges in the stock market...
ANET: 68.34 (+0.95), GILD: 100.46 (-2.70), AKRX: 37.55 (-2.17), JAZZ: 159.65 (-2.95), TASR: 22.85 (-0.02), CSCO: 26.58 (-0.10), CELG: 110.09 (-1.79)

Akorn (AKRX) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 8:10AM CST
Akorn (AKRX) Sees Hammer Chart Pattern: Time to Buy?
AKRX: 37.55 (-2.17)

Actavis Launches Generic of Shire's ADHD Drug Intuniv - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 5:45PM CST
Actavis (ACT) launched its generic version of Shire's attention deficit hyperactivity disorder drug Intuniv in the U.S.
AGN: 205.75 (-3.26), ACT: 256.52 (-6.48), AKRX: 37.55 (-2.17), SHPG: 208.76 (+0.28)

Teva First to Launch a Generic of Novartis' Exforge HCT - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 3:30PM CST
Teva (TEVA), which has launched its generic version of Novartis' Exforge HCT in the U.S., will enjoy 180 days exclusivity.
AKRX: 37.55 (-2.17), MYL: 53.56 (-0.96), TEVA: 55.15 (-0.47), NVS: 91.65 (+0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 126

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 135

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 17

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 134

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 211

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 28

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Equifax Unveils AI Advisory Service for Lenders' Success

Updated Category News Views 308

Empowering Lenders with Equifax Ignite AI Advisor Equifax has recently launched a transformative tool known as the Equifax Ignite AI Advisor, which is set to revolutionize how lenders operate. This innovative product aims to provide lenders with precise, actionable insights that can significantly improve decision-making processes and account growth. By leveraging advanced...

Continue Reading
Daily Overview: Spain's Stocks Experience Positive Surge

Updated Category News Views 153

Spain's Stock Market Closes on a Positive Note On a recent trading day, stocks in Spain showcased an encouraging uptick, particularly noted after the closing bell rang on Friday. The uptrend was primarily driven by gains in various sectors, which included Consumer Goods, Chemical, Petroleum & Plastic, as well as Telecoms & IT. These sectors played a vital role in...

Continue Reading
AGCO Celebrates Tiina Herlevi's 2025 Women MAKE Award Win

Updated Category News Views 195

AGCO Celebrates Leadership in Manufacturing AGCO, an acknowledged leader in the world of agricultural machinery and precision ag technology, has proudly announced that Tiina Herlevi has been honored with the 2025 Women MAKE Award. This prestigious recognition comes as a testament to her unwavering commitment to excellence and innovation within the manufacturing sector....

Continue Reading
eGain Delivers Impressive Q1 2026 Performance and Guidance

Updated Category News Views 206

Introduction to eGain's Financial Journey With an unwavering commitment to enhancing customer experience (CX) through AI automation, eGain Corporation (NASDAQ: EGAN) continues to make significant strides. Recently, eGain reported its fiscal 2026 first quarter results, showcasing impressive growth metrics and an optimistic outlook for the upcoming quarters. Q1 2026...

Continue Reading
Optimize Your Vehicle with Expert Multi-Point Inspection Services

Updated Category News Views 159

Optimize Your Vehicle with Expert Multi-Point Inspection Services Local drivers can take advantage of a multi-point inspection service at Auction Direct USA, designed to ensure their vehicles remain in peak condition. The Importance of Regular Vehicle Inspections Maintaining your vehicle's health is essential for both safety and longevity. Regular multi-point inspections...

Continue Reading